Screening for latent tuberculosis in migrants - status quo and future challenges

Eskild Petersen, Seif Al-Abri*, Amina Al-Jardani, Ziad A. Memish, Eleni Aklillu, Francine Ntoumi, Peter Mwaba, Christian Wejse, Alimuddin Zumla, Fatma Al-Yaquobi

*Corresponding author

Publikation: Bidrag til tidsskriftReviewpeer review

Abstract

Objectives: To review the evidence that migrants from tuberculosis (TB) high-incidence countries migrating to TB low-incidence countries significantly contribute to active TB cases in the counties of destination, primarily through reactivation of latent TB. Methods: This is a narrative review. The different screening programs in the countries of destination are reviewed either based on screening and preventive treatment of latent TB pre or more commonly – post arrival. Results: Screening can be performed using interferon-gamma release assays (IGRA) or tuberculin skin tests (TST). Preventive treatment of latent TB is using either monotherapy with isoniazid, or in combination with rifampicin or rifapentine. We discuss the ethical issues of preventive treatment in asymptomatic individuals and how these are addressed in different screening programs. Conclusion: Screening migrants from TB high endemic countries to TB low endemic countries is beneficial. There is a lack of standardization and agreement on screening protocols, follow up and treatment.

OriginalsprogEngelsk
Artikelnummer107002
TidsskriftInternational Journal of Infectious Diseases
Vol/bind141
Antal sider8
ISSN1201-9712
DOI
StatusUdgivet - apr. 2024

Citer dette